Pirtobrutinib met the primary endpoint of response rate non-inferiority, favoring pirtobrutinib with a nominal P-value for superiority < 0.05. Progression-free survival data was immature, but trending in favor of pirtobrutinib. BRUIN CLL-314 is the first-ever head-to-head Read More
India, 11th August 2025 Eyestem Research Pvt Ltd has raised funds in a significantly oversubscribed funding round to support the next stage of development for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPE™. The capital Read More
Dubai, UAE, 25 July 2025 Nooria, the premium Swiss dietary supplement brand known for its clean, science-backed formulations, has officially launched its Personalized Supplement Program in the UAE. This innovative solution offers a tailor-made supplement plan designed Read More
Swift diagnosis and emergency surgery prevent fatal complications for Indian expatriate. Untreated infections – whether in the ear, sinuses, or teeth—can quietly spread to the brain and become life-threatening. 4 August 2025; Ras Al Khaimah, UAE In Read More
Findings from the TRAILBLAZER-ALZ 2 long-term extension study highlight Kisunla continued to demonstrate slowing of decline, with most participants having completed treatment Data underscores the value of early intervention and supports a limited duration dosing approach Read More
